European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.61% to 1,444.24 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by Sequans Communications (SQNS) and financial services company ING Groep (ING), which rose 6.8% and 4.2% respectively. They were followed by financial services company Banco Santander (SAN) and biopharmaceutical company Genfit (GNFT), which were up 2.2% each.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and pharmaceutical company Novo Nordisk (NVO), which fell 3.7% and 2.1% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Cellectis (CLLS), which lost 1.9% and 1.3% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which advanced 16.7% and 8.8% respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company Verona Pharma (VRNA), which increased 3.5% and 1.7% respectively.
The decliners from the UK and Ireland were led by educational publisher Pearson (PSO) and hospitality company InterContinental Hotels Group (IHG), which dropped 3.6% and 3.1% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and cruise line operator Carnival (CUK), which were down 5% and 2.9% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。